Compare AU
Compare FEMX vs. EDOC
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Fidelity Global Emerging Markets Active ETF (FEMX) and the BetaShares Digital Health and Telemedicine ETF (EDOC). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
FEMX | EDOC | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 120 | 10 |
Median incremental investment | $1,002.19 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,518.40 | $621.34 |
Average age group | > 35 | > 35 |
Key Summary
FEMX | EDOC | |
|---|---|---|
Strategy | FEMX.AX was created on 2013-12-16 by Fidelity. The fund's investment portfolio concentrates primarily on total market equity. To achieve returns in excess of the MSCI Emerging Markets Index NR over the suggested minimum investment time period of seven years plus. | EDOC.AX was created on 2022-03-30 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. The investment objective of the BetaShares Digital Health and Telemedicine ETF is to provide an investment return that aims to track the performance of the NASDAQ CTA Global Digital Health Index (the Index), before taking into account fees and expenses. |
Top 3 holdings | Taiwan Semiconductor Manufacturing Co Ltd (8.00 %) Naspers Ltd Class N (5.58 %) HDFC Bank Ltd (4.96 %) | INSULET CORP (8.47 %) BOSTON SCIENTIFIC CORP (8.24 %) ABBOTT LABORATORIES (7.76 %) |
Top 3 industries | Financials (28.61 %) Information Technology (26.60 %) Consumer Discretionary (20.97 %) | Health Care (75.06 %) Other (24.70 %) Consumer Staples (14.33 %) |
Top 3 countries | India (24.10 %) China (17.96 %) Taiwan (13.38 %) | United States (77.51 %) China (13.32 %) Japan (4.67 %) |
Management fee | 0.99 % | 0.67 % |
Key Summary
FEMX | EDOC | |
|---|---|---|
Issuer | Fidelity | BetaShares |
Tracking index | MSCI EM (Emerging Markets) | Nasdaq CTA Global Digital Health Index - AUD - Benchmark TR Net |
Asset class | ETF | ETF |
Management fee | 0.99 % | 0.67 % |
Price | $6.42 | $10.33 |
Size | $186.975 million | $1.525 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.28 % | - % |
Market | ASX | ASX |
First listed date | 05/11/2018 | 29/03/2022 |
Purchase fee | $6.50 | $6.50 |
Community Stats
FEMX | EDOC | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 120 | 10 |
Median incremental investment | $1,002.19 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,518.40 | $621.34 |
Average age group | > 35 | > 35 |
Pros and Cons
FEMX | EDOC | |
|---|---|---|
Pros |
|
|
Cons |
|
|
FEMX | EDOC |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |